Conditions: Sjogren's Syndrome
Keywords: Ocular inflammation
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 97
Healthy volunteers: yes

Brief summary:
The primary purpose of this study is to quantify the change in expression of biomarkers on the ocular surface of Sjogren's Syndrome participants after treatment with Maxidex.

Detailed description:

Arms:
arm 1: Maxidex arm 2: Healthy normal control group receiving no treatment

Interventions: intervention 1: Maxidex intervention 2: No treatment
Intervention descriptions: intervention 1: Maxidex (0.1% Dexamethasone) 1 drop in each eye 2 times daily intervention 2: Healthy normal control group receiving no treatment

Protocol document: